Perioperative testosterone therapy linked to higher 5-year risk of periprosthetic joint infection without increased 90-day major complications or revision rates in total shoulder arthroplasty.

Lawand JJ, Crutchfield C, Holle AM, Sogbein OA, Khawaja SR, Ghilzai U, Hill BW, Khan AZ, Horneff JG, Abboud JA

Open source

DOI
10.1177/17585732261437972
Published
2026 Apr 7
Container
Shoulder & elbow
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17585732261437972,
  title = {Perioperative testosterone therapy linked to higher 5-year risk of periprosthetic joint infection without increased 90-day major complications or revision rates in total shoulder arthroplasty.},
  author = {Lawand JJ and Crutchfield C and Holle AM and Sogbein OA and Khawaja SR and Ghilzai U and Hill BW and Khan AZ and Horneff JG and Abboud JA},
  year = {2026},
  journal = {Shoulder \& elbow},
  doi = {10.1177/17585732261437972},
  url = {https://doi.org/10.1177/17585732261437972}
}

RIS

TY  - JOUR
TI  - Perioperative testosterone therapy linked to higher 5-year risk of periprosthetic joint infection without increased 90-day major complications or revision rates in total shoulder arthroplasty.
AU  - Lawand JJ
AU  - Crutchfield C
AU  - Holle AM
AU  - Sogbein OA
AU  - Khawaja SR
AU  - Ghilzai U
AU  - Hill BW
AU  - Khan AZ
AU  - Horneff JG
AU  - Abboud JA
PY  - 2026
JO  - Shoulder & elbow
DO  - 10.1177/17585732261437972
UR  - https://doi.org/10.1177/17585732261437972
ER  - 

APA

JJ, L., C, C., AM, H., OA, S., SR, K., U, G., BW, H., AZ, K., JG, H., & JA, A. (2026). Perioperative testosterone therapy linked to higher 5-year risk of periprosthetic joint infection without increased 90-day major complications or revision rates in total shoulder arthroplasty.. Shoulder & elbow. https://doi.org/10.1177/17585732261437972

Source records